Cargando…
Epigenetics as a mechanism driving polygenic clinical drug resistance
Aberrant methylation of CpG islands located at or near gene promoters is associated with inactivation of gene expression during tumour development. It is increasingly recognised that such epimutations may occur at a much higher frequency than gene mutation and therefore have a greater impact on sele...
Autores principales: | Glasspool, R M, Teodoridis, J M, Brown, R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361257/ https://www.ncbi.nlm.nih.gov/pubmed/16495912 http://dx.doi.org/10.1038/sj.bjc.6603024 |
Ejemplares similares
-
Common variants in polygenic schizophrenia
por: Glessner, Joseph T, et al.
Publicado: (2009) -
Intragenic DNA methylation: implications of this epigenetic mechanism for cancer research
por: Shenker, N, et al.
Publicado: (2012) -
Evaluation of polygenic risk score for risk prediction of gastric cancer
por: Wang, Xiao-Yu, et al.
Publicado: (2023) -
Epigenetic mechanisms in migraine: a promising avenue?
por: Eising, Else, et al.
Publicado: (2013) -
Small-Molecule Inhibitors of Chikungunya Virus: Mechanisms of Action and Antiviral Drug Resistance
por: Kovacikova, Kristina, et al.
Publicado: (2020)